Gold prices tick higher on fresh US tariff threats, Fed rate cut hopes
Director of Sera Prognostics (NASDAQ:SERA), Mirza Mansoor Raza, sold 225 shares of Class A Common Stock on August 5, 2025, at a price of $2.5, for a total transaction value of $562. The transaction comes as the stock trades near $2.45, down over 15% in the past week and showing significant volatility. According to InvestingPro analysis, the company appears undervalued at current levels, while maintaining a stronger cash position than debt on its balance sheet.
The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units, as per a pre-arranged "sell to cover" arrangement mandated by Sera Prognostics. Following the transaction, Mirza Mansoor Raza directly owns 58,702 shares of Sera Prognostics, representing a stake in the company’s $92.68 million market capitalization. Get deeper insights into SERA’s insider trading patterns and 8 additional key metrics with InvestingPro’s comprehensive research report.
In other recent news, Sera Prognostics reported its first-quarter 2025 earnings, revealing a narrower-than-expected loss. The company posted an earnings per share (EPS) of -$0.20, surpassing analysts’ forecast of -$0.27. However, revenue was reported at $38,000, which fell short of the anticipated $200,000 but marked an increase from zero revenue in the same quarter of the previous year. In addition to the earnings report, Sera Prognostics has made significant leadership changes. Lee Anderson was appointed as the new Chief Commercial Officer, bringing over 30 years of healthcare leadership experience. His previous roles at Genomic Health and Exact Sciences (NASDAQ:EXAS) were noted for contributing to revenue growth and successful product launches. Furthermore, Sera Prognostics held its annual stockholders meeting, where Jane F. Barlow, M.D., and Mansoor Raza Mirza, M.D., were elected as Class I directors for a three-year term. The company also ratified its auditor during this meeting.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.